Clinical Trial Update: FID-007 in Treating Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This clinical trial update reports on the Phase 1 study of FID-007 for advanced solid tumors, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• FID-007

Snippet

Sponsor: University of Southern California | Conditions: Advanced Malignant Solid Neoplasm, Refractory Malignant Solid Neoplasm | Phase 1 | Status: ACTIVE_NOT_RECRUITING